Lilly will sell a version of its popular insulin at half the price, but will this appease critics?
(By Ed Silverman for STAT) As drug makers come under increasing pressure to lower prices, Eli Lilly (LLY) is trying
Read More(By Ed Silverman for STAT) As drug makers come under increasing pressure to lower prices, Eli Lilly (LLY) is trying
Read MoreYou have until March 31t to drop the Medicare Advantage pan you are not satisfied with and switch over to
Read More(By Sydney Lupkin and Elizabeth Lucas and Victoria Knight for Kaiser Health News) Dozens of patient advocacy groups, like the
Read More(By Lev Facher for STAT) WASHINGTON — A legal setback in Maryland has state legislatures across the country re-examining their
Read More(By Jay Hancock for Kaiser Health News) Large majorities of Americans from both major parties support steps to control prescription
Read More(By Alia Paavola for Becker’s Hospital Review) Seven pharmaceutical executives, representing $140 billion in U.S. revenue, testified before the Senate Finance Committee
Read More(By Morgan Haefner for Becker’s Hospital Review) The Department of Justice formally requested a judge sign off on its settlement
Read More(By Emmarie Huetteman and Jay Hancock for Kaiser Health News) Senators got their first opportunity Tuesday to prod drugmakers about
Read More(By Alia Paavola for Becker’s Hospital Review) Seven pharma executives will testify Feb. 26 before a U.S. Senate Finance Committee
Read More(By Emmarie Huetteman and Jay Hancock for Kaiser Health News) Expect sparks to fly Tuesday as senators get a rare
Read More